DocDollars

Penumbra, Inc.

CA · United States · Reporting entity ID 100000010583

Total reported 2019–2025
$48.5M
#178 of 2,960 reporting companies — 0.1% of all reported industry payments
$31.1M in general payments across 107,180 records, plus $17.4M in research funding across 7,383 records.

How it breaks down

General payments $31,148,409
Research funding $17,358,494

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Penumbra, Inc. reported $48.5M to US doctors and teaching hospitals from 2019 to 2025, ranking #178 of 2,960 reporting companies. 36% of that was research funding and 64% general payments such as consulting, speaking, food and travel. 107,180 general payment records and 7,383 research records were filed.

Common questions about Penumbra, Inc.

How much has Penumbra, Inc. paid US doctors?

Penumbra, Inc. reported $48,506,902 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $31,148,409 in general payments, $17,358,494 in research funding.

How does Penumbra, Inc. rank among drug and device companies?

It ranks #178 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Penumbra, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.